Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [1]; ; ; ; ;  [2];  [2]
  1. Department of Bioindustry Technology, Da-Yeh University, Taiwan (China)
  2. Department of Biomedical Sciences, Chung Shan Medical University, Taiwan (China)

Cisplatin is a chemotherapeutic agent widely used in the treatment of various cancers. However, cisplatin can induce nephrotoxicity and neurotoxicity, limiting its dosage and usage. Galangin, a natural flavonol, has been found to exhibit anti-oxidant and anti-inflammatory effects in vivo. Here, we investigated the effects of galangin on cisplatin-induced acute kidney injury (AKI) and its molecular mechanisms in mice. Galangin administration reduced the cisplatin-induced oxidative stress by decreasing renal MDA and 3-NT formations. Galangin administration also increased renal anti-oxidative enzyme activities (SOD, GPx, and CAT) and GSH levels depleted by cisplatin. Furthermore, galangin administration inactivated stress-induced Nrf2 protein and its downstream products, HO-1 and GCLC. In terms of the inflammatory response, galangin administration reduced IκBα phosphorylation, NF-κB phosphorylation and nuclear translocation, and then inhibited cisplatin-induced secretions of pro-inflammatory TNF-α, IL-1β and IL-6. In addition, cisplatin-induced ERK and p38 phosphorylations were inhibited by galangin administration. In terms of cell death, galangin administration reduced levels of p53, pro-apoptotic Bax and activated caspase-3 to inhibit the cisplatin-induced apoptosis. Galangin administration also reduced the expression levels of RIP1 and RIP3 to inhibit cisplatin-induced RIP1/RIP3-dependent necroptosis. Therefore, galangin administration significantly ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation, and cell death through inhibitions of ERK and NF-κB signaling pathways. Galangin might be a potential adjuvant for clinical cisplatin therapy. - Highlights: • Galangin alleviates cisplatin-induced acute kidney injury through ERK and NF-kappaB signaling pathways. • Galangin reduces cisplatin-induced oxidative stress and inflammatory response. • Galangin suppresses cisplatin-induced cell death, apoptosis and necroptosis.

OSTI ID:
22722893
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Vol. 329; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: Possible mechanism of nephroprotection
Journal Article · Thu May 15 00:00:00 EDT 2014 · Toxicology and Applied Pharmacology · OSTI ID:22439711

Taurine protects HK-2 cells from oxidized LDL-induced cytotoxicity via the ROS-mediated mitochondrial and p53-related apoptotic pathways
Journal Article · Mon Sep 15 00:00:00 EDT 2014 · Toxicology and Applied Pharmacology · OSTI ID:22439833

Role of necroptosis in autophagy signaling during hepatic ischemia and reperfusion
Journal Article · Sat Oct 01 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:22690799